-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MS8Y1k+d3p2GiE8RzlyM2q4+WxffzWE/mZDT6INSfrusz9p3rAUwf5ulNr0Uz134 SQmck01oWp45Gj516tZr7A== 0001266375-07-000050.txt : 20070705 0001266375-07-000050.hdr.sgml : 20070704 20070705171346 ACCESSION NUMBER: 0001266375-07-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070702 FILED AS OF DATE: 20070705 DATE AS OF CHANGE: 20070705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boyd Thomas A CENTRAL INDEX KEY: 0001327433 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 07965323 BUSINESS ADDRESS: BUSINESS PHONE: (914) 789-2800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-07-02 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001327433 Boyd Thomas A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Product Dev. Common Stock 2007-07-02 4 A 0 9333 0 A 36160 D Common Stock 2007-07-02 4 M 0 545 18.71 A 36705 D Common Stock 2007-07-02 4 F 0 496 22.01 D 36209 D ESPP (right to buy) 18.71 2007-07-02 4 M 0 545 0 D 2007-07-02 2007-07-03 Common Stock 545 0 D ESPP (right to buy) 21.57 2007-07-02 4 A 0 493 0 A 2008-01-02 2008-01-02 Common Stock 493 493 D Non-Qualified Stock Option (right to buy) 22.01 2007-07-02 4 A 0 7000 0 A 2008-07-02 2017-07-02 Common Stock 7000 7000 D Restricted Stock shall be released in four equal installments, commencing one year from the transaction date. Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date. The stock options become exercisable in four equal installments, commencing one year from the grant date. Thomas A. Boyd 2007-07-05 -----END PRIVACY-ENHANCED MESSAGE-----